Articles producció científica> Bioquímica i Biotecnologia

Gut microbiota in nonalcoholic fatty liver disease: a PREDIMED-Plus trial sub analysis

  • Identification data

    Identifier: imarina:9324082
  • Authors:

    Gómez-Pérez, AM
    Ruiz-Limón, P
    Salas-Salvadó, J
    Vioque, J
    Corella, D
    Fitó, M
    Vidal, J
    Atzeni, A
    Torres-Collado, L
    Alvarez-Sala, A
    Martínez, MA
    Goday, A
    Benaiges, D
    García-Gavilán, J
    López, MRB
    Moreno-Indias, I
    Tinahones, FJ
  • Others:

    Author, as appears in the article.: Gómez-Pérez, AM; Ruiz-Limón, P; Salas-Salvadó, J; Vioque, J; Corella, D; Fitó, M; Vidal, J; Atzeni, A; Torres-Collado, L; Alvarez-Sala, A; Martínez, MA; Goday, A; Benaiges, D; García-Gavilán, J; López, MRB; Moreno-Indias, I; Tinahones, FJ
    Department: Bioquímica i Biotecnologia
    URV's Author/s: Atzeni, Alessandro / García Gavilán, Jesús Francisco / Martínez Rodríguez, María Ángeles / Salas Salvadó, Jorge
    Keywords: The fibrosis-4 score Non-alcoholic fatty liver disease Microbiome Metabolic syndrome Metabolic liver disease Mediterranean diet Liver Humans Hepatic steatosis index Gastrointestinal microbiome Gastric bypass Fibrosis the fibrosis-4 score metabolic liver disease mediterranean diet intervention hepatic steatosis index acid
    Abstract: To evaluate the changes in the gut microbiota associated with changes in the biochemical markers of nonalcoholic fatty liver disease (NAFLD) after a lifestyle intervention with the Mediterranean diet. Participants (n = 297) from two centers of PREDIMED-Plus trial (Prevención con Dieta Mediterránea) were divided into three different groups based on the change tertile in the Hepatic Steatosis Index (HSI) or the Fibrosis-4 score (FIB-4) between baseline and one year of intervention. One-year changes in HSI were: tertile 1 (T1) (-24.9 to -7.51), T2 (-7.5 to -1.86), T3 (-1.85 to 13.64). The most significant differences in gut microbiota within the year of intervention were observed in the T1 and T3. According to the FIB-4, participants were categorized in non-suspected fibrosis (NSF) and with indeterminate or suspected fibrosis (SF). NSF participants showed higher abundances of Alcaligenaceae, Bacteroidaceae, Bifidobacteriaceae, Clostridiaceae, Enterobacteriaceae, Peptostreptococcaceae, Verrucomicrobiaceae compared to those with SF. Then, participants were divided depending on the FIB-4 tertile of change: T1 (-89.60 to -5.57), T2 (-5.56 to 11.4), and T3 (11.41 to 206.24). FIB-4 T1 showed a decrease in Akkermansia and an increase in Desulfovibrio. T2 had an increase in Victivallaceae, Clostridiaceae, and Desulfovibrio. T3 showed a decrease in Enterobacteriaceae, and an increase in Sutterella, Faecalibacterium, and Blautia. A relation between biochemical index changes of NAFLD/NASH (HSI and FIB-4) and gut microbiota changes were found. These observations highlight the importance of lifestyle intervention in the modulation of gut microbiota and the management of metabolic syndrome and its hepatic manifestations.
    Thematic Areas: Microbiology (medical) Microbiology Medicina veterinaria Medicina i Infectious diseases Gastroenterology & hepatology Gastroenterology Ciências biológicas iii Ciências biológicas i Ciência de alimentos Biotecnología
    licence for use: https://creativecommons.org/licenses/by/3.0/es/
    Author's mail: jesusfrancisco.garcia@urv.cat alessandro.atzeni@urv.cat mangeles.martinez@urv.cat jesusfrancisco.garcia@urv.cat alessandro.atzeni@urv.cat jordi.salas@urv.cat
    Author identifier: 0000-0002-1804-8606 0000-0001-8595-3772 0000-0002-1804-8606 0000-0003-2700-7459
    Record's date: 2024-07-20
    Papper version: info:eu-repo/semantics/publishedVersion
    Link to the original source: https://www.tandfonline.com/doi/full/10.1080/19490976.2023.2223339
    Licence document URL: http://repositori.urv.cat/ca/proteccio-de-dades/
    Papper original source: Gut Microbes. 15 (1): 2223339-
    APA: Gómez-Pérez, AM; Ruiz-Limón, P; Salas-Salvadó, J; Vioque, J; Corella, D; Fitó, M; Vidal, J; Atzeni, A; Torres-Collado, L; Alvarez-Sala, A; Martínez, M (2023). Gut microbiota in nonalcoholic fatty liver disease: a PREDIMED-Plus trial sub analysis. Gut Microbes, 15(1), 2223339-. DOI: 10.1080/19490976.2023.2223339
    Article's DOI: 10.1080/19490976.2023.2223339
    Entity: Universitat Rovira i Virgili
    Journal publication year: 2023
    Publication Type: Journal Publications
  • Keywords:

    Gastroenterology,Gastroenterology & Hepatology,Infectious Diseases,Microbiology,Microbiology (Medical)
    The fibrosis-4 score
    Non-alcoholic fatty liver disease
    Microbiome
    Metabolic syndrome
    Metabolic liver disease
    Mediterranean diet
    Liver
    Humans
    Hepatic steatosis index
    Gastrointestinal microbiome
    Gastric bypass
    Fibrosis
    the fibrosis-4 score
    metabolic liver disease
    mediterranean diet
    intervention
    hepatic steatosis index
    acid
    Microbiology (medical)
    Microbiology
    Medicina veterinaria
    Medicina i
    Infectious diseases
    Gastroenterology & hepatology
    Gastroenterology
    Ciências biológicas iii
    Ciências biológicas i
    Ciência de alimentos
    Biotecnología
  • Documents:

  • Cerca a google

    Search to google scholar